Health Economics and Epidemiology Research Office - HE2RO

06/11/2025

Meet Mazvita Mnangagwa https://www.heroza.org/staffmembers/mazvita-mnangagwa/ who will be presenting today at the Wits School of Public Health Biennial Research Day. day

06/11/2025

Meet Nomsa Mahlalela https://www.heroza.org/staffmembers/nomsa-mahlalela/ who will be presenting at the Wits School of Public Health Biennial research day today. day

06/11/2025

Join us today at the Wits School of Public Health Biennial Research day.

Theme: Accelerating Equitable Policy and Practice Through Public Health Research in Africa.

03/11/2025

The Lancet series on Innovations in Sexual & Reproductive Health is officially live! https://authors.elsevier.com/a/1m146V-4XSikU

We are incredibly proud to have been asked to contribute a rapid review of the cost and cost-effectiveness of SRH interventions and future funding implications.

Key takeaway: Our paper summarises Who pays, and what pays off, in SRG. It provides a summary of what is known about the funding, cost, and cost-effectiveness of sexual and reproductive health and rights interventions, interrogates the likely impacts of increasing or reducing future sexual and reproductive health and rights funding, and provides recommendations for policy and regulatory changes from an economic perspective. Interventions that target HIV and sexually transmitted infections, contraceptive interventions, and abortion care are among the most cost-effective health interventions worldwide, but their funding is under severe duress. In 2023, approximately US$35 billion was spent on these intervention areas across low-income and middle-income countries—only two thirds of the $52 billion needed per year. HIV treatment and prevention, as well as contraceptive commodities, rely heavily on donor funding, which has decreased since 2017. The discontinuation of the US Agency for International Development funding in early 2025, in particular, requires that the most impacted countries will have to do more with much less going forward. We found that across interventions, cost-effectiveness was improved by expanding eligible population groups, coverage, uptake, and demand, including through community provision, as well as improving retention in care, earlier care initiation, and integrated programming. We recommend that scaling up cost-effective interventions to population-level impact will require programme and market interventions aimed at expediting to regulatory approval and the implementation of novel therapeutic and diagnostic interventions, delivery outside of facilities (including through self-care), accommodating rapidly changing options and user choice within integrated prevention systems, and closing policy and financing gaps for contraceptive and abortion care.

A huge thank you to Prof Gesine Meyer-Rath, Dr Lise Jamieson and the rest of the HE2RO team for this timely work.

Read the full paper here: https://ow.ly/ZWMu50XlRyq

31/10/2025

Happening now,

The Lancet Innovations in Sexual & Reproductive Health Series Launch. Join the live stream here: https://www.youtube.com/watch?v=UMhXdWTwHsM

31/10/2025

We're live at the US launch for The Lancet SRH series!

Link to live stream -

On October 31, 2025, Fenway Health will host the Boston launch of The Lancet's five-paper series on sexual and reproductive health, edited by Profs. Kenneth ...

31/10/2025

New publication alert!

We are thrilled to announce that our paper has been published as part of the new "The Lancet series on Innovations in Sexual & Reproductive Health".

See links to the article to read more: https://ow.ly/l09P50XkL4b.

https://www.heroza.org/publications/who-pays-and-what-pays-off-in-sexual-and-reproductive-health-a-review-of-the-cost-and-cost-effectiveness-of-interventions-and-implications-for-future-funding-and-markets/

This Series paper provides a summary of what is known about the funding, cost, and cost-effectiveness of sexual and reproductive health and rights int…

31/10/2025

The day is finally here! Join the US launch event for The Lancet series on Innovations in Sexual & Reproductive Health (SRH). Tune in virtually https://www.youtube.com/watch?v=UMhXdWTwHsM to hear from the Prof Gesine Meyer-Rath and Dr Lise Jamieson’s presentation on costs and funding of SRH interventions. Presentations are scheduled from 9:00-11:30am ET.

Watch the livestream here :https://www.youtube.com/watch?v=UMhXdWTwHsM

On October 31, 2025, Fenway Health will host the Boston launch of The Lancet's five-paper series on sexual and reproductive health, edited by Profs. Kenneth ...

30/10/2025

New publication alert!

Leveraging community pharmacies for HIV services in South Africa: Opportunities and constraints

Link to article: https://ow.ly/mlvG50Xkp9n

29/10/2025

Earlier today, we were proudly represented by Nthabiseng Masebe at the University of the Witwatersrand’s Faculty of Health Sciences Mental Health and Neuroscience Fair. She presented our work in this important space with excellence. Well done Nthabiseng and thank you for representing us so well!

28/10/2025

We are at the SA Mental Health Conference. Meet Nelly Jinga https://ow.ly/4cpG50XiZm2 and Sithabile Mngadi-Ncube https://ow.ly/oVn050XiZm3 sharing their presentations.

23/10/2025

New publication alert!

Experiences of testing negative or positive for HIV in Malawi, South Africa, and Zambia: A Cross-sectional study.

Link to full article: https://ow.ly/xCUa50XgvFL